A detailed history of Cwm, LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Cwm, LLC holds 793 shares of KOD stock, worth $7,826. This represents 0.0% of its overall portfolio holdings.

Number of Shares
793
Previous 21 3676.19%
Holding current value
$7,826
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$2.2 - $3.25 $1,698 - $2,509
772 Added 3676.19%
793 $2,000
Q2 2024

Jul 09, 2024

BUY
$2.29 - $4.48 $32 - $62
14 Added 200.0%
21 $0
Q1 2024

Apr 05, 2024

BUY
$3.01 - $7.45 $21 - $52
7 New
7 $0
Q2 2023

Aug 03, 2023

BUY
$4.3 - $9.48 $430 - $948
100 New
100 $1,000
Q1 2022

Apr 21, 2022

SELL
$7.09 - $89.45 $14 - $178
-2 Closed
0 $0
Q4 2021

Jan 31, 2022

BUY
$80.85 - $128.49 $161 - $256
2 New
2 $0

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $514M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.